January 5, 2026

NRG Oncology Broadcast archives are accessible from our website at any time. Please bookmark this link for your convenience.

Registration is OPEN for #NRG2026!

Registration is OPEN for the NRG 2026 Winter Meeting

Join us at the Hilton San Francisco Union Square for the NRG 2026 Winter Meeting. The meeting will be held in-person, January 22-24, 2026, with select virtual sessions being held January 12-16, and January 20, 2026.

HOTEL REGISTRATION DEADLINE EXTENDED UNTIL JANUARY 9, 2026

NOTE: MDs and DOs who attend the meeting in-person and register for both the NRG Meeting and Winter Symposium will receive a bundle discount for a total fee of $325.00 USD. ($140.00 USD savings). Please use the discount code IPCOMBOMTGSYM.



More information | Agenda | Register

Winter 2026 Symposium – Theranostics: Precision Imaging Meets Targeted Therapy

Join us in San Francisco, CA on Thursday, January 22, 2026, from 8am-12pm PT. The session will also be available virtually. This symposium will provide a comprehensive look at theranostics and radiopharmaceutical therapy. The program will begin with an introduction to the scientific foundations of radiopharmaceuticals, outlining how these agents differ from external beam radiation, and the practical considerations of imaging, dosimetry, and safe delivery. Participants will gain insight into the operational, regulatory, and infrastructural requirements needed to build a successful theranostics program within their institution.

Program Chair: Denise Fabian, MD and Co-Chairs: Charles Kunos, MD/PhD; Elise Kohn, MD

More information | Register

Announcing the #NRG2026 Investigator & Career Development Committee Educational Session!

This year’s program explores protocol development from every angle—early-career investigators shaping their first studies, experienced leaders refining best practices, NRG operations guiding feasibility, experts addressing health care access, and insights from a disease site committee leader. Additional information is included on the session flyer.

Communications & Digital Engagement Workshop

The NRG Oncology Communications Committee is pleased to announce our Communications & Digital Engagement (CDE) Workshop as part of #NRG2026. The workshop, being held as a virtual session, is scheduled for Tuesday, January 20, 2026, 1-2pm ET (10-11am PT). Drs. Kristin Higgins and Miriam Knoll, members of the NRG Oncology Communications Committee, are the session chairs. The speakers include Dr. Nina Sanford, GI radiation oncologist at UT Southwestern Medical Center and chair of the NRG Pancreas GI Subsite Working Group, who will discuss how she uses social media to drive scientific dialogue; and Jason Tharp, a member of NRG’s Patient Advocate Committee, a brain cancer survivor turned keynote speaker, author of 23+ books, and founder of the Beyond Hope Project. Additional information is included on the session flyer.

NRG Scientific Session - Friday, January 23, 3-4:30pm PT

Join us for the #NRG2026 Scientific Session featuring updates on antibody–drug conjugates and novel approaches in breast and ovarian cancer, followed by highlights from top recent NRG abstracts presented at national meetings. Details are included on the session flyer.

NCORP Bootcamp at #NRG2026

Join NRG Oncology NCORP leaders for the NCORP 2026 Bootcamp designed to increase understanding of the NRG Oncology NCORP Research Base and NCORP Community Sites:

• Dr. Lisa Kachnic will provide an overview of the functions and strategic role of an NCORP Research Base.
• Dr. Carolyn Muller, PI of the University of New Mexico NCORP, will share insights from the field describing the operations and impact of an NCORP community site.

A panel discussion will focus on developing and enrolling to NCORP trials, with perspectives from both.

All attendees are invited to participate in interactive breakout groups focused on:

• Patient advocate engagement - To help investigators strengthen their NCORP concepts by integrating patient advocate perspectives early in development ensuring trials are understandable, feasible, and meaningful to participants.
• CPC, HCA, and PCOR committees – learn more about NCORP concept development, collaboration with NRG committees, and integration of health care access throughout NRG trial development.
• Developing a framework for Advanced Practice Providers within NRG Oncology.

The #NRG2026 Bootcamp is being held on Thursday, January 22, 2026. Additional information is included on the session flyer.

NRG Protocol Support Committee – Continuing Education Sessions

Please join the Protocol Support Committee for their upcoming Continuing Education sessions being held during #NRG2026 in San Francisco on Thursday, January 22, 2026. The Continuing Education Session for Nurse/CRAs on Thursday morning will be held virtually and in-person and is for both seasoned and new research staff. The monthly Discuss With Us session is being held in-person only and will cover topics including Onboarding & Retention, Biospecimen Collection & QOLs, and more! The Protocol Spotlight session on Thursday afternoon will be held in-person and virtually and will discuss the following studies – NRG-GU015, NRG-HN014, and NRG-CC014. Please refer to the posted agendas (login required) and flyers for more details about the PSC programing offered during #NRG2026. These sessions have been approved by the Virginia Nurses Association to award contact hours. The Virginia Nurses Association is accredited as an approver of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

SUMMARY OF RESEARCH RESULTS FOR PATIENTS  

A summary of research results is available on the NRG Patient Study Materials webpage for the following studies. Sites, please share the summary of research results with study participants.

BREAST: NSABP B-51/RTOG 1304

GYNECOLOGIC: NRG-GY007

OTHER PROTOCOL NOTICES

1. ALL DISEASE SITES

NRG-GY022: Reminder: Actively Recruiting MALE Patients only (posted on CTSU)

2. BIOSPECIMEN BANK

Important Update: Kit Shipments to Sites in Canada

The NRG Oncology Biospecimen Bank - Columbus thought the issues with shipments of kits had been resolved, but many kits continue to be delayed or rejected at customs. We apologize for the inconvenience. While our institution continues to work on resolving this issue, we must once again ask sites in Canada to provide their FedEx account number to cover duties and taxes at the time they order kits. Please note this is a temporary measure being instituted to allow the kits to pass through customs. We will provide an update once access to the CARM portal has been established. Please direct questions to:

NRG Biospecimen Bank - Columbus

• Phone: 614-722-2865
• Email: BPCBank@nationwidechildrens.org

Printing Biospecimen Transmittal PDFs from Rave

Please note an effort is underway to clarify how to obtain a Biospecimen Transmittal PDF for submission to the NRG Oncology Biospecimen Bank. Read More

3. CANCER PREVENTION & CONTROL

NRG-CC005/FORTE: FORTE Fridays Newsletter

NRG-CC005/FORTE: Clinical research professionals can sign up for NRG Oncology Weekly Broadcasts to receive monthly FORTE Fridays updates directly to your inbox (click here).

4. GENITOURINARY

NRG-GU010: Spanish Translated Informed Consent Form, dated November 14, 2025, posted on CTSU.

NRG-GU011: Please see Study Memorandum dated November 17, 2025 (posted on CTSU), regarding shipment timelines during the holidays. To avoid delays, submit shipment requests as soon as possible to support subject visits scheduled between November 10, 2025, and January 10, 2026.

NRG-GU013: QOL Substudy closed to accrual, dated December 22, 2025, and updated Pathology Correlative instructions posted on CTSU. 

5. GYNECOLOGIC

NRG-GY026: Accruing patients of all stages and all histologic subtypes of endometrial cancer.

NRG-GY031: Please note there is an error in the section 4.2 table and the Biospecimen Collection and Submission Manual. The Part I PK collection is to be done on Cycle 1, Day 1, and Cycle 1, Day 8. This will be updated with the next amendment.

NRG-GY037 requires blocks to be submitted, but the study team recognizes variations in site operating procedures to release blocks. Please refer to the Letter to Pathologists in the Biospecimen Collection and Submission Manual. If your site is experiencing any issues with this requirement, please contact the study team as we can work with sites on a case-by-case basis to ensure patients have an opportunity to participate in this trial.

6. HEAD & NECK

NRG-HN008 - Reminder: please update treatment and AE data weekly. This is a Phase I trial and timely data submission is very important.

7. VTOC TRAINING

The VTOC Webinar Training Series schedule and registration is available for NRG Oncology Research Associates working on NRG-BN014, NRG-BR009, NRG-CC005, NRG-CC011, NRG-CC013, NRG-CC014, NRG-CC015, NRG-GI011, NRG-GI012, NRG-GU015, and NRG-HN014. Space is limited so register now and reserve your seat. The next webinar training is scheduled for January 14, 2026.

Safety updates have been issued for the following studies:

1. PSC – Discuss With Us Recording

The recording from the December 2025 session is now posted on the Discuss With Us page on the NRG Oncology website.

2. NRG Mentorship Subcommittee Update

Are you a new CRA or CTN within NRG Oncology? Would you like a mentor to help guide you through your new role as a CRA or CTN? Are you an institution in need of more guidance after an audit? The Mentorship Subcommittee can provide you with a mentor! You can apply for a mentor by going to the Introductory Materials page on the NRG website. You will find the Mentor Form to complete. The instructions on how to submit are located on the form. Hope to hear from you soon!

3. NRG Oncology Current Committee Leadership Openings

•  Vice Chair, Ancillary Projects Committee 

Applications DUE January 7, 2026 - Read more & How to Apply



•  Vice Chair, Protocol Operations Management Committee 

Applications DUE January 7, 2026 - Read more & How to Apply

 NRG Oncology Current Committee Openings

• Patient Advocate Committee (PAC) 

Applications DUE January 15, 2026 - Read more & How to Apply

4. NRG Member Information Form

We are excited to introduce the NRG Member Information Data Collection Initiative that will allow us to create a comprehensive member database, enabling us to better understand and serve our members. Your information will be kept secure and confidential, ensuring that your privacy is always protected. All members are encouraged to complete the form or indicate that they wish to opt out of this data collection initiative. 

Scan the QR code below or click this link to access the form. 

Questions? Read more here

NRG Oncology is pleased to report the following scientific articles that have appeared during the previous week as well as abstract accepted for presentation at the annual meeting of the Society of Gynecologic Oncology.

This publications report includes links, when available, to the article, PubMed abstract, or association abstract.

ACCEPTED ABSTRACTS

Clements A, Enserro DM, Strickland K, Previs RA, Matei D, Mutch DG, Powell MA, Klopp AH, Miller D, Small W, Jr., DiSilvestro PA, Spirtos NM, Cosgrove CM, Sfakianos G, Liu R, Vargas R, Shahin MS, Corr B, Dessources K, Ueland FR, Warshal D, Gillen J, Green MF, Hastings SB; Secord AA: POLE mutation analysis, molecular characterization, and associations with survival outcomes: Ancillary analysis of GOG-0258. Society of Gynecologic Oncology (SGO). Focused Oral Presentation.

PUBLISHED ATRICLES

Langer CJ, Harris J, Horwitz EM, Kies M, Ad VB, Wong SJ, Caudell JJ, Zeitzer KL, Spencer SA, Zhang Q, Yom SS, Le QT. Phase II Study of Low-Dose Paclitaxel and Cisplatin in Combination With Split-Course Concomitant Twice-Daily Reirradiation in Recurrent Squamous Cell Carcinoma of the Head and Neck: Long-term Follow-up of NRG Oncology RTOG 9911. Int J Radiat Oncol Biol Phys. 2026 Jan 1;124(1):50-60. doi: 10.1016/j.ijrobp.2025.07.1434. Epub 2025 Jul 31. PMID: 40752652. Read more.

Morgan TM, Ren Y, Tang S, Zwerink W, Chen E, Mitani A, Huang HC, Simko JP, DeVries S, Pollack A, Wilke D, Martin AG, Balogh AG, Michalski JM, Greenberg MJ, Efstathiou JA, Bahary JP, Ross AE, Esteva A, Royce TJ, Nguyen PL, Hoffman KE, Sandler HM, Tran PT, Pugh SL, Feng FY, Spratt DE. Development and Validation of a Multimodal Artificial Intelligence-derived Digital Pathology-based Biomarker Predicting Metastasis Among Patients with Biochemical Recurrence After Radical Prostatectomy in NRG/RTOG Trials. Eur Urol. 2025 Dec 22:S0302-2838(25)04859-6. doi: 10.1016/j.eururo.2025.12.007. Epub ahead of print. PMID: 41436315. Read more.

Runge CL, Lyness JA, Gillison ML, Adelstein DJ, Harari PM, Ringash J, Geiger JL, Krempl GA, Blakaj DM, Bates JE, Galloway TJ, Jones CU, Gensheimer MF, Dunlap NE, Phan J, Caudell JJ, Pennington JD, Torres-Saavedra PA, Yom SS, Le QT, Movsas B. Self-Perceived Hearing Outcomes With Radiation and Cisplatin or Radiation and Cetuximab for Patients With Human Papilloma Virus (HPV)-Positive Oropharyngeal Cancer-Results From NRG Oncology RTOG 1016. Int J Radiat Oncol Biol Phys. 2026 Jan 1;124(1):61-69. doi: 10.1016/j.ijrobp.2025.08.021. Epub 2025 Aug 18. PMID: 40829719; PMCID: PMC12637033. Read more. 

Please note the following upcoming meetings and abstract submission deadlines

UPCOMING MEETINGS

American Head & Neck Society (AHNS) Annual Meeting; Jul 18-22, 2026; Boston, MA

American Radium Society (ARS) Annual Meeting; Apr 30-May 3, 2026; Newport Beach, CA

American Society of Clinical Oncology (ASCO) GI; Jan 8-10, 2026; San Francisco, CA

American Society of Clinical Oncology (ASCO) GU; Feb 26-28, 2026; San Francisco, CA

European Society of Gynaecological Oncology (ESGO); Feb 26-Mar 1, 2026; Copenhagen, Denmark 

Society for Clinical Trials (SCT); May 17-20, 2026; Phoenix, AZ

Society of Surgical Oncology (SSO) – Annual Meeting; Mar 5-7, 2026; Phoenix, AZ

Society of Surgical Oncology (SSO) – Advanced Cancer Therapies; Feb 14-16, 2026; Fort Lauderdale, FL

UPCOMING ABSTRACT SUBMISSION DEADLINES

American Association for Cancer Research (AACR); Apr 17-22, 2026; San Diego, CA; LBA and Clinical Trials Jan 12, 2026, 11:59 pm ET

American Brachytherapy Society (ABS); Jun 17-20; Los Angeles, CA; Due to publications committee Feb 4, 2026; Submission deadline Feb 18, 2026, 6:00 pm CT

American College of Radiology (ACR); May 2-6, 2026; Washington, DC; Due to publications committee Jan 12, 2026; Submission deadline Jan 26, 2026, 11:59 pm ET

American Society of Breast Surgeons (ASBrS); Apr 29-May 3, 2026; Seattle, WA; LBA Jan 9, 2026, 12:00 am PT

American Society of Clinical Oncology (ASCO); May 29-Jun 2, 2026; Chicago, IL; Due to publications committee Jan 13, 2026; Submission deadline Jan 27, 2026, 11:59 pm ET; LBA Mar 9, 2026, 12:00 pm ET (placeholder required)

American Society of Colon and Rectal Surgeons (ASCRS); May 9-12, 2026; Tampa, FL; LBA and Clinical Trials Jan 28, 2026, 12:00 pm CT

American Society for Radiation Oncology (ASTRO); Boston, MA; Sep 27-30, 2026; Due to publications committee Feb 10, 2026; Submission deadline Feb 24, 2026, 11:59 pm PT; LBA Apr 20, 2026 (placeholder required)

European Society of Gynaecological Oncology (ESGO); Feb 26-Mar 1, 2026; Copenhagen, Denmark; LBA Jan 15, 2026

ESMO (European Society for Medical Oncology) Breast; May 6-8, 2026; Berlin, Germany; Due to publications committee Jan 13, 2026; Submission deadline Jan 27, 2026, 21:00 CST; LBA Mar 31, 2026, 21:00 CST (placeholder required)

ESMO Gynaecological; Jun 17-19, 2026; Copenhagen, Denmark; Due to publications committee Mar 17, 2026; Submission deadline Mar 31, 2026, 21:00 CET



European Society for Radiotherapy and Oncology (ESTRO); May 15-19, 2026; Stockholm, Sweden; LBA Apr 8, 2026

International Society for Quality-of-Life Research (ISOQOL); Oct 18-21, 2026; Prague, Czech Republic; Due to publications committee Mar 23, 2026; Submission deadline Apr 6, 2026

Miami Breast Cancer Conference; Mar 5-8, 2026; Miami, FL; Submission deadline Jan 5, 2026, 5:00 pm ET